| 24 HIV-specific, ex vivo expanded T cell therapy (HXTC) for HIV clearance: feasibility, safety and efficacy JM Sung, JAD Kuruc, M Clohosey, A Crooks, S Patel, L Roesch, P Hanley, ... Journal of Virus Eradication 3, 15, 2017 | | 2017 |
| A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria … SJ Dunachie, M Walther, JE Epstein, S Keating, T Berthoud, L Andrews, ... Infection and immunity 74 (10), 5933-5942, 2006 | 206 | 2006 |
| A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression SR Himes, H Tagoh, N Goonetilleke, T Sasmono, D Oceandy, R Clark, ... Journal of leukocyte biology 70 (5), 812-820, 2001 | 101 | 2001 |
| A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells JJ Peterson, CA Lewis, SD Burgos, A Manickam, Y Xu, AA Rowley, ... Cell Chemical Biology 30 (12), 1617-1633. e9, 2023 | 6 | 2023 |
| A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses E Prieur, SC Gilbert, J Schneider, AC Moore, EG Sheu, N Goonetilleke, ... Proceedings of the National Academy of Sciences 101 (1), 290-295, 2004 | 83 | 2004 |
| A reproducible, objective method using MitoTracker® fluorescent dyes to assess mitochondrial mass in T cells by flow cytometry G Clutton, K Mollan, M Hudgens, N Goonetilleke Cytometry Part A 95 (4), 450-456, 2019 | 28 | 2019 |
| A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies D Liu, C Wang, B Hora, T Zuo, N Goonetilleke, MKP Liu, M Berrong, ... Retrovirology 14, 1-9, 2017 | 2 | 2017 |
| Adoptive T cell as a strategy for targeted delivery of immune checkpoint therapy J Sung, BD Walker, M Clohosey, J Kirchherr, Y Xu, J Warren, N Archin, ... | | 2017 |
| AIDS Vaccine 2013October 7–10, 2013Barcelona, Spain T Hertz AIDS Research and Human Retroviruses 29 (11), A-1, 2013 | 1 | 2013 |
| Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1 M Sanz, AMK Weideman, AR Ward, ML Clohosey, S Garcia-Recio, ... Frontiers in Immunology 14, 1219250, 2023 | | 2023 |
| An early HIV mutation within an HLA-B* 57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1 S Brackenridge, EJ Evans, M Toebes, N Goonetilleke, MKP Liu, ... Journal of virology 85 (11), 5415-5422, 2011 | 64 | 2011 |
| An expanded population of CD8dim T cells with features of mitochondrial dysfunction and senescence is associated with persistent HIV-associated Kaposi’s sarcoma under ART GT Clutton, AMK Weideman, NP Goonetilleke, T Maurer Frontiers in Cell and Developmental Biology 10, 961021, 2022 | 2 | 2022 |
| Anti‐chlamydia IgG and IgA are insufficient to prevent endometrial chlamydia infection in women, and increased anti‐chlamydia IgG is associated with enhanced risk for incident … T Darville, HL Albritton, W Zhong, L Dong, CM O'Connell, TB Poston, ... American journal of reproductive immunology 81 (5), e13103, 2019 | 27 | 2019 |
| Antigen Processing Takes a New Direction N Goonetilleke, AJ McMichael Science 340 (6135), 937-938, 2013 | 4 | 2013 |
| Antisense-Derived HIV-1 cryptic Epitopes are not major drivers of viral evolution P Borrow, B Peng, M Liu, F Gao, N Goonetilleke, A McMichael, J Gilmour, ... Journal of Virology 92, 2018 | | 2018 |
| Antisense-derived HIV-1 cryptic epitopes are not major drivers of viral evolution during the acute phase of infection BJ Peng, JM Carlson, MKP Liu, F Gao, N Goonetilleke, AJ McMichael, ... Journal of Virology 92 (19), 10.1128/jvi. 00711-18, 2018 | 4 | 2018 |
| Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection CL Gay, JD Kuruc, SD Falcinelli, JA Warren, SA Reifeis, JL Kirchherr, ... Scientific Reports 10 (1), 5134, 2020 | 47 | 2020 |
| Blocking formation of the stable HIV reservoir: a new perspective for HIV-1 cure N Goonetilleke, G Clutton, R Swanstrom, SB Joseph Frontiers in Immunology 10, 1966, 2019 | 28 | 2019 |
| Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials H McShane, AA Pathan, CR Sander, NP Goonetilleke, HA Fletcher, ... Tuberculosis 85 (1-2), 47-52, 2005 | 178 | 2005 |
| Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs A Williams, NP Goonetilleke, H McShane, SO Clark, G Hatch, SC Gilbert, ... Infection and immunity 73 (6), 3814-3816, 2005 | 122 | 2005 |
